PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 32: Articles 15501-16000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraception: a risk factor for endometriosis.
  2. Contraceptive behavior in sexually active college women: a study of personality, background, and environmental influences.
  3. Contraceptive behavior of 16-18 year-old girls born in 1967-1970. [Antikoncepcni chovani 16 az 18letych divek narozenych 1967 az 1970.]
  4. Contraceptive behaviour of women aged over 35.
  5. Contraceptive choice in the completed family.
  6. Contraceptive devices as a cause of urethritis. [Spirale przeciwciazowe jako powod zapalenia cewki moczowej.]
  7. Contraceptive discontinuation among married women in the United States.
  8. Contraceptive efficacy among women at increased genetic risk.
  9. Contraceptive implants: clinical experience and future prospects. [Kontrasepsi implant: pengalaman klinik serta prospek masa depan.]
  10. Contraceptive innovations: needs and opportunities.
  11. Contraceptive knowledge and use in Mpraeso, Kwahu district of Ghana.
  12. Contraceptive knowledge, attitudes and behavior among Nigerian males: Benin City and Udo, 1986.
  13. Contraceptive knowledge, attitudes and behaviors of black adolescent males attending a predominately black university.
  14. Contraceptive knowledge, private self-consciousness, private body consciousness, and contraceptive problem solving: an information processing approach.
  15. Contraceptive method change: a study in rural Sri Lanka.
  16. Contraceptive method switching in Peninsular Malaysia: ethnic differences, 1940s-1970s.
  17. Contraceptive method-switching in Sri Lanka: patterns and implications.
  18. Contraceptive needs of women over 35.
  19. Contraceptive needs through stages of women's reproductive lives.
  20. Contraceptive pill study points to poor compliance.
  21. Contraceptive potential of antibodies to the zona pellucida.
  22. Contraceptive potential of GnRH antagonists.
  23. Contraceptive potential of secretory immunity.
  24. Contraceptive practice of the Thai MWRA, 1987: an advance report of the study of the determinants and consequences of contraceptive use patterns in Thailand.
  25. Contraceptive prevalence survey in the gouvernorat of Tunis. [Enquete sur la prevalence de la contraception dans le gouvernorat de Tunis.]
  26. Contraceptive safety: an overview.
  27. Contraceptive safety: rumors and reality.
  28. Contraceptive safety: rumours and realities.
  29. Contraceptive services for ethnic minorities [letter]
  30. Contraceptive social marketing (CSM) assessment.
  31. The contraceptive social marketing project in review.
  32. Contraceptive sterilization in Flanders. A situation report for the 1970s, 1980s, and 1990s. [Anticonceptieve sterilisatie in Vlaanderen. Een situatieschets voor de jaren zeventig, tachtig en negentig.]
  33. Contraceptive sterilization.
  34. Contraceptive steroids alter the steady-state kinetics of bile acids.
  35. Contraceptive technology, 1988-1989, 14th revised edition.
  36. Contraceptive use and fertility in Paraguay, 1987.
  37. Contraceptive use by women with chronic diseases. Sickle cell disease.
  38. Contraceptive use in a sample of young Danish females.
  39. Contraceptive use in Africa.
  40. Contraceptive use in fertility transition: changing motives, changing actions.
  41. Contraceptive use in the chronically ill adolescent female. Response [letter]
  42. Contraceptive use in the chronically ill adolescent female] [letter.
  43. Contraceptive vasectomy: study based on 1385 cases between 1975 and 1986. [Vasectomie. Criteres de choix ou protocole?]
  44. Contraceptives. [Anticonceptivos.]
  45. Contraceptives: break due after decade of drought.
  46. Copper intrauterine contraceptive devices and serum essential metals.
  47. Copper: a possible male contraceptive.
  48. Correlates and determinants of husband-wife communication about family planning in Egypt.
  49. Correlates of fertility behaviour in Pakistan: some evidence from the Pakistan Contraceptive Prevalence Survey.
  50. Correlates of the contraceptive behavior of adolescents/young adults.
  51. A cost-based decision analysis for Chlamydia screening in California family planning clinics.
  52. Costs, payments, and incentives in family planning programs: a review for developing countries.
  53. Counseling with family planning clients about AIDS.
  54. Country fact sheets: family planning in Latin America and the Caribbean.
  55. A critical evaluation of hormonal contraceptives. [Avaliacao critica dos contraceptivos hormonais.]
  56. Culturally appropriate strategies for a community-based distribution system of contraceptives in Chad. [Elaborer des strategies culturellement appropriees pour un systeme de distribution communautaire de contraceptifs au Tchad.]
  57. Culturally-appropriate strategies for a community-based distribution system of contraceptives in Chad. [Elaborer des strategies culturellement appropriees pour un systeme de distribution communautaire de contraceptifs au Tchad.]
  58. Culture and the management of family planning programs.
  59. Culture, family planning and the number of children.
  60. Current primary investigation on the view of family planning of Chinese peasants.
  61. A current status method for estimating contraceptive use-failure rates.
  62. Cytologic picture of smears from the cervix uteri of women using intrauterine contraceptive devices (IUD) [Obrazy cytologiczne rozmazow z szyjki macicy kobiet stosujacych wewnatrzmaciczne wkladki antykoncepcyjne (WWA)]
  63. Czechoslovakia 1985 Family Planning Survey [MRDF]
  64. Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.
  65. Decision of 11 April 1984 of the Council of Ministers establishing the National Committee on Population and Family Planning.
  66. Decreased pituitary suppression with deliberate oral contraceptive pill omission [abstract]
  67. Decree No. 88-129/PCMS/MSP/AS prescribing procedures for the implementation of Ordinance No. 88-19 of 7 April 1988 authorizing the practice of contraception, 7 April 1988.
  68. Decree relating to health education and information on youth as well as to aid and assistance to families in areas relating to contraception and responsible parenting, 10 July 1984.
  69. Delivering surgical contraception services in outlying areas.
  70. The delivery of family planning and health services in Great Britain.
  71. The delivery of family planning services in Ontario and Quebec.
  72. The delivery of family planning services in the Netherlands.
  73. The delivery of family planning services in the United States.
  74. Demand for and cost-benefit analysis of family planning services in the private sector in Nigeria.
  75. The demand for family planning: a new approach.
  76. The demand for family planning: fact and fiction.
  77. Demographic study on the family planning behaviour of the German population: the importance of natural methods.
  78. Depo-Provera -- anti-cancer agent which is also a contraceptive. [Depo-Provera: cancermedicinen som blev preventivmedel.]
  79. Dermatological complications caused by oral contraceptives. [Complications dermatologiques des contraceptifs oraux.]
  80. Determinants of contraceptive use dynamics: the case of Mexico.
  81. Determinants of contraceptive use.
  82. The development and use of graphically presented algorithms in community-based family planning services.
  83. Development of a multiphasic combination oral contraceptive utilizing norethisterone.
  84. The development of population and family planning programmes in Peru.
  85. Differences by race in contraceptive choice have complex origins.
  86. Differing perspectives on family planning provision: the NHS regions, the districts and the consumer.
  87. The difficulties of contraception: conflicts and paradoxes. [Les difficultes de la contraception: conflits et paradoxes.]
  88. Dimensions of counseling in family planning.
  89. Directory of hormonal contraceptives. 1988. [Repertoire des contraceptifs hormonaux. Guia de anticonceptivos hormonales.]
  90. Divorced women's sexual and contraceptive issues.
  91. Do family planning facilities meet the needs of the sexually active teenagers?
  92. Do oral contraceptives increase risk of contracting HIV?
  93. Do women take the oral contraceptive pill correctly?
  94. Does cigarette smoking alter platelet aggregation in women receiving the contraceptive pill?
  95. Does family planning reduce infant mortality?
  96. Does increasing contraception decrease infant mortality?
  97. The domestic servant as family planning innovator: an Indian case study.
  98. Draft team member contributions to mid-term evaluation of the Population and Family Planning Project (608-0171) in Morocco.
  99. Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database.
  100. A dynamic model of contraceptive choice.
  101. The dynamics of contraceptive adoption in Bohol, Philippines: 1976-1978.
  102. Early oral contraceptive use as a prognostic factor in breast cancer.
  103. Echographic evaluation of the incrustation of intrauterine contraceptive devices (IUD)
  104. The economic crisis and population policy: the Algerian strategy for dealing with family planning. [Crise economique et politique de population: approche de la strategie algerienne de limitation des naissances.]
  105. Economy or culture? The introduction of birth control in the town of Stavanger, Norway, 1900-1935. [Economie ou culture? L'introduction de la prevention des naissances dans la ville de Stavanger, Norvege, 1900-1935.]
  106. Ectopic pregnancy during the use of intrauterine contraceptive devices. [Ektopicheskaia beremennost pri primenenii vnutrimatochnykh kontratseptivov.]
  107. Ecuador Family Planning Baseline KAP Study.
  108. Education -- the key to Indonesia's family planning programme.
  109. Education and family planning among black American women.
  110. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
  111. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
  112. Effect of betel chewing on the frequency of sister chromatid exchanges in pregnant women and women using oral contraceptives.
  113. Effect of butoconazole nitrate cream and wax insert on the barrier property of contraceptive devices.
  114. Effect of combined oral contraceptives on the hypophyseo-thyroid and hypophyseo-adrenal systems in women with various anatomy of the thyroid gland. [Vliianie kombinirovannykh oralnykh kontratseptivov na gipofizarno-tireoidnuiu i gipofizarno-nadpochechnikonuiu sistemu zhenshchin s razlichnym anatomicheskim sostoianiem shchitovidnoi zhelezy.]
  115. Effect of contraceptives on the skin.
  116. Effect of family planning, economy and education on infant mortality.
  117. Effect of megestrol acetate compound (injectable contraceptive) on human blood coagulation, anticoagulation activity, fibrinolysis and platelet aggregation.
  118. Effect of oral contraceptive steroids on the clinical course of malaria infection and on the pharmacokinetics of mefloquine in Thai women.
  119. Effect of oral contraceptives on carbohydrate metabolism in healthy women.
  120. The effect of oral contraceptives on lumbar bone density in premenopausal women.
  121. The effect of socio-demographic, community and program level factors on contraceptive use and method choice among Costa Rican women.
  122. Effect of the administration of vitamin B6 at two levels of intake on xanthurenic acid excretion among oral contraceptive pill users.
  123. The effect of the media on the Moroccan public in the field of family planning and the protection of mothers and children and the population communication program.
  124. Effective family planning counseling: a CSI manual. Draft.
  125. Effects of a contraceptive hormone, danazol, on male sexual functioning.
  126. Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics.
  127. Effects of an oral contraceptive on lipid balance and on the concentration of serum tocopherol. [Effetti della somministrazione orale di un contraccettivo sull'assetto lipidico e sulla concentrazione di tocoferolo sierico.]
  128. The effects of cognitive and physical stress on cardiovascular reactivity among smokers and oral contraceptive users.
  129. The effects of contraceptive education on adolescent male contraceptive behavior and attitudes.
  130. Effects of demographic factors on the use and effectiveness of new contraceptive technologies.
  131. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
  132. The effects of family planning effort and development on fertility: an intervening variables framework.
  133. The effects of improved child survival on family planning practice and fertility.
  134. Effects of long term use of oral contraceptives on serum PRL and the response to oral administration of metoclopramide.
  135. The effects of low-dose estrogen-progestogen oral contraceptives on blood pressure and the renin-angiotensin system.
  136. Effects of new contraceptive methods on abortion utilization.
  137. Effects of oral contraception on blood clotting.
  138. Effects of oral contraceptives on serum lipids in women of reproductive age.
  139. Effects of plasma antithrombin III, fibrinopeptide A during use of oral contraceptives, and antithrombin III inhibitory effect of conjugated estrogen.
  140. Effects of triphasic oral contraceptives on tear production. [Effets des contraceptifs oraux triphases sur la secretion lacrymale.]
  141. Endometrial cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  142. Endometrial response to the use of a sequential oral contraceptive.
  143. Endoscopy for contraception.
  144. Enprostil, a synthetic prostaglandin E2 analogue, does not affect oral contraceptive bioavailability.
  145. Enterocolitis imitating Crohn's disease in connection with the use of oral contraceptives. [Crohn-betegseget utanzo enterocolitis oralis fogamzasgatlo-kezeles alatt.]
  146. Epidemiological studies of natural family planning.
  147. Establishment of human-mouse hybridoma to human seminal plasma antigen and its contribution to a contraceptive vaccine.
  148. Estimation of delivery date after withdrawal of oral contraceptives. [Bestemmelse av fodselstermin etter seponering av p-pille.]
  149. Ethical issues in family planning.
  150. Ethics and human values in family planning.
  151. Evaluating client autonomy in natural family planning.
  152. Evaluating steroidal contraceptives: pre-clinical and clinical approaches.
  153. Evaluation of a human sexuality and family planning training program for human service professionals.
  154. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics.
  155. Evaluation of family planning services in the community program of SMMISA (Servicio Medico Materno Infantil "San Alfonso") [Evaluacion de los servicios de planificacion familiar en el programa comunitario del S.M.M.I.S.A.]
  156. Evaluation of the Norplant subdermal implant contraceptive system -- China.
  157. Evaluation of the use of Lippes loop, Multiload Cu 250 and Nova T contraception. [Die unter verschiedenen Gesichtspunkten durchgefuhrte Bewertung des Lippes Loop, Multiload CU 250 und Nova T.]
  158. Experience with intrauterine contraception. Survey of 600 IUD users at the S. Anna University Hospital in Rome. [Esperienze di contraccezione intrauterina. Rilievi su 600 utenti di IUD presso l'Ospedale Universitario S. Anna in Roma.]
  159. Experimental training program, natural family planning, level on level system. [Programa Experimental de Capacitacion, Planificacion Familiar Natural, sistema pareja a pareja.]
  160. The extent of unmet need for family planning in Mexico.
  161. F.D.A. approves cervical cap as a device for birth control.
  162. Facilitating family planning education to the rural dwellers in Nigeria -- how well is environmental health officers involvement?
  163. Factors related to non-use of contraception among couples with an unmet need for family planning in Nepal.
  164. Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma.
  165. Faltering commitment to family planning?
  166. Family formation and family planning attitude of unmarried rural adolescent girls in Andhra Pradesh.
  167. Family planning accessibility as a determinant of contraceptive use and birth rate: the case of Nigeria.
  168. Family planning among Southeast Asian refugees.
  169. Family planning and child mental health in China: the Nanjing survey.
  170. Family planning and child survival: 100 developing countries.
  171. Family planning and community development: an indissoluble partnership. [La planification familiale et le developpement communal: une dualite indissociable.]
  172. Family planning and counseling manual for training of Level B health workers in the Primary Health Care Programme.
  173. Family planning and development: issues in inter-agency coordination in Uttar Pradesh.
  174. Family planning and IMR.
  175. Family planning and maternal-child health: an analysis of the current situation and its implications.
  176. Family planning and the male adolescent. Part 2. Sex counselling of the male adolescent.
  177. Family planning and the politics of population control in Nigeria.
  178. Family planning and welfare services for female workers in the manufacturing industry: pilot survey and cost-benefit analysis.
  179. Family planning and world health.
  180. Family planning as a priority for maternal and child health.
  181. Family planning as part of a population policy, an incentive to the development of a population policy for Suriname.
  182. Family planning associations support themselves.
  183. The family planning central unit and public health medicine.
  184. Family planning counselling in an antenatal clinic.
  185. Family planning handbook for doctors. 6th ed.
  186. Family planning improves world health. [Planeamento familiar melhora saude no mundo.]
  187. Family planning in Chile and its effect on health indicators. [La planificacion familiar en Chile y su efecto sobre los indices de salud.]
  188. Family planning in China: recent trends.
  189. Family planning in Nepal.
  190. Family planning in Pakistan.
  191. Family planning in the Peruvian Amazon.
  192. Family planning in the Sudan.
  193. Family planning knowledge, attitudes and practices of young men and women in the greater Banjul region of the Gambia.
  194. Family planning linked to an obstetric service.

     

  195. Family planning logistics management project.
  196. Family planning maintains safe motherhood.
  197. Family planning measures, February 1988.
  198. Family planning needs in colleges of education. Report of a study of 20 colleges in Kenya.
  199. Family planning needs: an empirical study of federal responsiveness before and during the Reagan administration.
  200. Family planning operations research/Asia project, progress report, March 1, 1988-August 31, 1988.
  201. Family planning policy in Niger. [La politique sur la planification familiale: document au Niger.r.]
  202. Family planning practice among Nigerian student midwives.
  203. Family planning procedure manual for health workers, Division of Family Health 1988.
  204. Family planning program in China.
  205. Family planning programme in Pertamina.
  206. Family planning project for troubled teens in Anchorage, Alaska.
  207. Family planning propaganda outline, 1988.
  208. Family planning provider and contraceptive care setting: the relationship to contraceptive behavior.
  209. Family Planning Regulations, 2 November 1988.
  210. Family planning saves mothers life.
  211. Family planning service provision and AIDS prevention in Zaire: competing or complementary strategies?
  212. Family planning services and prevention of HIV transmission, opportunities and constraints in services for high risk groups.
  213. Family planning services in Sub-Saharan Africa.
  214. Family planning services.
  215. Family planning statistics for the first half of 1988. [Statistiques de planning familial au cours du premier semestre 1988.]
  216. Family planning statistics, for 1987. [Statistiques de planning familial, au cours de l'annee 1987.]
  217. Family planning survey in N'Djamena: preliminary report (August 1988) [Rapport preliminaire: enquete sur le bien etre familial a N'Djamena (Aout 1988)]
  218. Family Planning Survey, Paraguay 1987. Final English language report.
  219. Family planning training evaluation manual.
  220. Family planning uses traditional theater in Mali.
  221. Family planning without doctors.
  222. Family planning--key to fertility decline in Brazil.
  223. Family planning.
  224. Family planning.
  225. Family planning. Current levels and trends in contraceptive use. [Planificacion familiar. Niveles y tendencias recientes del uso de anticonceptivos.]
  226. Family planning: a new perspective.
  227. Family planning: the great hoax.
  228. Family planning: wages of "target-orientation".
  229. Feminist ethical perspectives in the international family planning field.
  230. Fertility and adoption of family planning among Muslims of 24 Parganas, West Bengal (Part-I)
  231. Fertility and contraception in the Marshall Islands.
  232. Fertility and contraception patterns in a tribal area of Madhya Pradesh.
  233. Fertility and contraception. Las Tunas, 1985. [Fecundidad y anticoncepcion. Las Tunas, 1985.]
  234. Fertility and contraceptive knowledge and practice in the major cities of Bolivia. [Fecundidad, conocimientos y practicas anticonceptivas en las principales ciudades de Bolivia.]
  235. Fertility and Contraceptive Prevalence Survey, Las Tunas, 1985. General report. [Encuesta de Fecundidad y Prevalencia de Metodos Anticonceptivos, Las Tunas, 1985. Informe general.]
  236. Fertility and family planning in sub-Saharan Africa.
  237. Fertility and family planning in the third world: a case study of Papua New Guinea.
  238. Fertility and family planning in the United States: insights from the National Survey of Family Growth.
  239. Fertility and legal abortion in England and Wales: performance indicators for family planning services.
  240. Fertility decline and consequences of the National Family Planning Program: an analysis of the achievements of family planning activities in Chiang Mai and Lamphun provinces.
  241. The fertility history card: clinical use in improving contraceptive efficacy.
  242. Fertility studies for the benefit of animals and human beings: development of improved sterilization and contraceptive methods.
  243. Final pre-test report: Atlantic Coast campaign. Ref: Condones Tahiti and oral contraceptives. [Reporte final pre-test: campana Costa Atlantica. Ref: Condones Tahiti y pastillas anticonceptivas.]
  244. Final report of a course held in Abidjan in November 1988 on management of primary health care programs, including maternal and child health and family planning for the countries of francophone Africa and the West Indies. [Rapport final du cours tenu a Abidjan en Novembre 1988 sur gestion de programmes de soins de sante primaires y compris la sante matenelle et infantile et la planification familiale pour les pays de l'Afrique Francophone et des Antilles.]
  245. Final report of the study: Relationship of Personality to Teenage Pregnancy, Sexual Relations and Contraceptive Practices: the Case of Mexico.
  246. Final report of the [first] International Family Planning Conference in Chad: N'Djamena October 15-21, 1988] [Rapport final de la conference sur le bien-etre familial au Tchad: N'Djamena 15-21 Ocobre 1988.]
  247. Final report summary, Population Communication Services, Johns Hopkins University, project LA-BRA-01. Associacao Brasileira de Entidades de Planejamento Familiar (ABEPF): Family Planning IEC Activities.
  248. Final report summary: Population Communication Services, Johns Hopkins University project LA-HON-01, MOH Family Planning IEC Activities.
  249. Final report: "Improved Worker Utilization: a Path to Expanded Family Planning Coverage in Asuncion, Paraguay", CEPEP (Centro Paraguayo de Estudios de Poblacion). Contract No. CI87.06A, March 1, 1987 - September 30, 1988.
  250. Final report: "Integrating Family Planning Services and Women's Development Activities", ADIM (Asociacion para el Desarrollo e Integracion de la Mujer), Contract No. CI86.13A / CI87.78A, May 1, 1986 - May 31, 1988.
  251. Final report: Cooperative Agreement No. AID/DPE-3005-A-00-1049-00, Tunisia National Family Planning Program, 30 September 1981 - 31 August 1987.
  252. Final technical report: "Family Planning Service Delivery Strategies in an Industrial Setting", MIPFAC (Materno-Infantil y Planificacion Familiar de Ciudad Juarez, Chihuahua). Contract No. CI86.02A, February 1, 1986 - January 31, 1988.
  253. Financing the delivery of contraceptives: the challenge of the next twenty years.
  254. Finding the keys to success: what makes family planning and primary health care programs work?
  255. Follicular ovarian cysts appearing during progestin or estroprogestin oral contraception at low doses. [Les kystes folliculaires ovariens apparaissant lors de la contraception orale progestative ou oestroprogestative a faibles doses.]
  256. For patients, a cost-effective contraceptive is one that works.
  257. A framework for economic analysis of family planning projects: a case study of the planned Niger family health and demography project.
  258. A fresh look at barrier contraceptives.`.
  259. From oral contraception to hormone replacement therapy: towards a continuum?
  260. Functional communication model for family planning extension services in Kenya.
  261. Future developments in contraception.
  262. Future tasks related to contraception.
  263. Gender role conflict, future time perspective, and contraceptive behavior among unmarried black, white and Hispanic adolescent fathers and their nonfather peers.
  264. Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.
  265. Global contraceptive use improves health.
  266. Glossary of natural family planning terms.
  267. GnRH analogs in contraception.
  268. Gossypol and its related compounds as contraceptive drugs and drugs for gynecological diseases.
  269. Government positions and policies concerning fertility and family planning. [Les positions et politiques gouvernementales en matiere de fecondite et de planification familiale.]
  270. Guide for using the community-based distribution program for contraceptives in Zaire. [Guide pour la realisation du programme de distribution communautaire des contraceptifs au Zaire.]
  271. Guide to installing a monitoring system for family planning training in Vietnam.
  272. Guidelines on sexually-transmitted diseases and AIDS for family planning programmes.
  273. Gynecological risks of contraception in adolescents. [Les risques gynecologiques de la contraception chez l'adolescente.]
  274. Haemostasis and oral contraceptives.
  275. Haiti -- family planning on Rue Barbancourt.
  276. Haitian attitudes toward family planning and reactions to eight advertising concepts promoting family planning and contraceptives: a report on twelve focus group discussions.
  277. Half of the world's population practices contraception. [Metade da populacao mundial pratica contracepcao.]
  278. Half the world using contraception.
  279. Hand steadiness: effects of sex, menstrual phase, oral contraceptives, practice, and handgun weight.
  280. Health and family planning services in Lesotho: the people's perspective.
  281. Health and family planning: facts and issues.
  282. Health and population information as APLIC comes of age: proceedings of the twenty-first annual conference, Association for Population/Family Planning Libraries and Information Centers -- International, Hyatt Regency, New Orleans, Louisiana, April 19-21, 1988.
  283. Health for all: but where has all the family planning gone? [editorial]
  284. Health provider evaluations of contraceptives for teens.
  285. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
  286. Hemorrhagic cellular leiomyomas ("apoplectic leiomyoma") of the uterus associated with pregnancy and oral contraceptives.
  287. High school students' attitudes towards and use of contraceptives.
  288. Hindu-Muslim differentials in family size ideals and contraceptive attitudes and practice in rural Uttar Pradesh.
  289. Hispanic and black American adolescents' beliefs relating to sexuality and contraception.
  290. Historical perspectives on contraceptive technology introduction.
  291. HIV positive women and contraception.
  292. Hormonal contraception and cystic fibrosis. (Answer to question) [Hormonelle Kontrazeption bei zystischer Fibrose.]
  293. Hormonal contraception in perimenopause.
  294. Hormonal contraception: current status and prescription. [Hormonska kontracepcija (sadasnje stanje i propisivanje)]
  295. Hormonal contraceptives in practice. [Hormonale Kontrazeption in der Praxis.]
  296. How family planning reduces infant mortality rates: a look beyond parity and spacing effects.
  297. How to overcome the socio-cultural and religious obstacles in family planning programs. [Comment vis-a-vis du bien-etre familial franchir les problemes socio-culturels et religieux s'opposant au programme du bien-etre familial.]
  298. How to overcome the socio-cultural religious and demographic obstacles in family planning programs. [Comment vis-a-vis du bien-etre familial franchir les problemes socio-culturels, religieux et demographiques s'opposant au programme du bien-etre familial.]
  299. Humoral immunity in oral contraceptive users. I. Plasma immunoglobulin levels.
  300. Humoral immunity in oral contraceptive users. II. In vitro immunoglobulin production.
  301. Husband's approval of contraceptive use in metropolitan Indonesia: program implications.
  302. Husband-wife attitudes toward family planning in Sri Lanka: husband-wife communication, contraceptive decision-making and consistency of reporting of contraceptive use.
  303. Husband-wife communication and status of women as a determinant of contraceptive use in rural Bangladesh.
  304. Husband-wife communication in family planning decisions in urban Ghana.
  305. Husbands' and wives' perceptions of their roles in household decisionmaking: implications for family planning use.
  306. Hypertension induced by pregnancy, oral contraceptives, and postmenopausal replacement therapy.
  307. IEC activities during Nigeria's first state-wide family planning campaign, Kwara State, 1984- 1987.
  308. IEC for the MCH/Family Planning Programme in Kenya.
  309. IEC for the MCH/Family Planning programme in Kenya.
  310. The illusion of unique invulnerability and the use of effective contraception.
  311. Immunisation knowledge of acceptors and practice of family planning.
  312. Immunodiffusion study of plasma anti thrombin III level in oral contraceptive pill users.
  313. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
  314. Immunoglobulins IgG, IgA and IgM in serum and uterine washings in women with intrauterine contraceptive devices.
  315. The impact of AIDS on family planning programs. Discussion summary.
  316. The impact of AIDS on family planning.
  317. The impact of AIDS on the use of condoms for family planning in Mexico: a SOMARC special study.
  318. Impact of contraception on the birth rate of Maharashtra.
  319. Impact of family planning on maternal-child health. [Impacto de la planificacion familiar en la salud materno-infantil.]
  320. Impact of family planning on maternal-child health. The future of humanity depends on our children. [Impacto de la planificacion familiar en la salud materno-infantil. El futuro de la humanidad depende de nuestros hijos.]
  321. Impact of the introduction of NORPLANT implants into the national family planning program of Thailand.
  322. Impact of the Mexico City policy on family planning programs and reproductive health care in developing countries.
  323. The impacts of health, education, family planning and electrification programs on fertility, mortality and child schooling in East Java, Indonesia.
  324. The implications of HIV for family planning programs.
  325. The importance of different reasons that minority teenagers give for not using birth control when they have sex.
  326. Importance of oral ketoconazole in family planning, especially in women using intra-uterine device.
  327. Improving geographic coverage of family planning in urban Chittagong: a report of an operations research project. Rev. ed.
  328. In-vivo measurement of spin lattice relaxation time (T1) of liver in healthy volunteers: the effects of age, sex and oral contraceptive usage.
  329. Inadvertent urethral insertion of a contraceptive suppository.
  330. Incentives for adoption of family planning: views of acceptors and motivators.
  331. Incorporating AIDS education in family planning.
  332. Indonesia family planning data sheet, 1987. [Lembaran data keluarga berencana Indonesia.]
  333. Indonesia family planning data sheet, 1988. [Lembaran data keluarga berencana Indonesia, 1988.]
  334. Indonesia launches "self-support" family planning campaign.
  335. Indonesia National Family Planning Program 1988/1989.
  336. Indonesia's successful family planning stems population growth: education is the key.
  337. Influence of oral contraceptive use on bone density in climacteric women.
  338. The influence of oral contraceptives on hormonal and metabolic homeostasis in young adolescents.
  339. Influence of oral contraceptives on normal human breast epithelial proliferation.
  340. Influence of oral contraceptives on selected hormonal and metabolic responses to prolonged submaximal exercise in moderately active women.
  341. Injectable and other types of steroid contraceptives.
  342. Injectable contraception.
  343. Innovative media promotion of family planning: Anglophone Africa.
  344. Ins and outs of family planning in Togo. [La planification familiale au Togo: tenants et aboutissants.]
  345. Ins and outs of health and population data: proceedings of the Twentieth Annual Conference, Association for Population/Family Planning Libraries and Information Centers--International.
  346. The integrated family planning and family health services. Country report: Indonesia.
  347. The Integrated Family Planning Project in China. FP and health education: a successful combination.
  348. The Integrated Family Planning Project in China. Introduction.
  349. The Integrated Family Planning Project: a look into the future.
  350. The Integrated Project on Family Planning, Parasite Control and Nutrition in the Philippines. Country paper.
  351. Integrating family planning in maternal and child health care services: the case of Mali. [Integration de la planification familiale dans le systeme de sante maternelle et infantile cas du Mali.]
  352. Intentions and behavior in women's contraception: an application of the theory of planned behavior.
  353. Inter and intra-tribal differences in attitudes towards family planning.
  354. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
  355. Interaction of infant mortality and fertility and the effectiveness of health and family planning programs.
  356. Interactions of contraceptive steroids with binding proteins and the clinical implications.
  357. Interactions of medications with oral contraceptives. [Interactions medicamenteuses des contraceptifs oraux.]
  358. International Conference on Better Health for Women and Children Through Family Planning: recommendations for action.
  359. International Planned Parenthood Federation annual report: 1987-1988.
  360. International Planned Parenthood Federation [IPPF. [La Federation Internationale pour La Planification Familiale (I.P.P.F.)]
  361. Intimal hyperplasia and thrombosis of the visceral arteries in a young woman: possible relation with oral contraceptives and smoking.
  362. Intraamniotic infection with Candida albicans associated with a retained intrauterine contraceptive device: a case report.
  363. Intracervical device may be effective hormonal contraceptive.
  364. Intrafollicular ovarian pregnancy in a woman using an intrauterine contraceptive device. [Ciaza jajnikowa wewnatrzpecherzykowa u kobiety stosujacej wewnatrzmaciczna wkladke antykoncepcyjna.]
  365. INTRAH's family planning training strategies: Chad. [Les strategies de formation INTRAH en matiere de planification familiale le cas du Tchad.]
  366. Intrahepatic biliary tract -- oral contraceptives. Electron microscopic examinations of 27 surgical liver biopsies.
  367. Intrahepatic cholestasis caused by oral contraceptives with early onset (letter) [Colestasis intrahepatica por anticonceptivos orales con comienzo precoz.]
  368. Intrauterine contraceptive device, clinical manual, 2nd ed.
  369. Intrauterine contraceptive device, clinical manual.
  370. Intrauterine contraceptive devices [letter]
  371. Introducing a new contraceptive technology: opportunities for assessment and innovation in existing programs.
  372. Introducing new contraceptive technologies in developing countries.
  373. Introduction of new contraceptives in Indonesia.
  374. Investigating the timing of additional children in non-contraceptive societies.
  375. Investigation of a model to predict contraceptive behavior in college women.
  376. IOC rescinds ban on birth control drug.
  377. Irregular supply of contraceptives results in dropouts in family planning use. Bangladesh.
  378. Is family planning already accepted by the present generation? Freshmen's view on family planning at University of North Sumatera, Medan. (Third report)
  379. Is family planning beneficial for our society? [La planification familiale est-elle benefique pour notre societe?]
  380. Is the Asian family planning program model suited to Africa?
  381. Ischemic papillopathy and contraceptives.
  382. Japan's family planning pioneer.

     

  383. Jewish law and contraceptive practice.
  384. Joint Circular on Planned Parenthood Propaganda, 1988.
  385. KAP study on sex, reproduction and contraception in Thai teenagers.
  386. The Kintambo Motivation project to increase clinic utilization in Kinshasa, Zaire, conducted by the Projet des Services des Naissances Desirables, as part of the Tulane family planning operations research project in Zaire.
  387. Knowledge and use of contraception in rural and urban Iraq.
  388. Knowledge of female Mexico City adolescents concerning sexual behavior and contraceptives. Results of a household survey. [Conocimientos de las adolescentes de la Ciudad de Mexico sobre la conducta sexual y los anticonceptivos. Resultado de una encuesta de hogares.]
  389. Knowledge on birth regulation methods and contraception in women in reproductive age. [Wiedza o metodach regulacji urodzen i stosowanie antykoncepcji wsrod kobiet w wieku rozrodczym.]
  390. A knowledge, attitude and practice (KAP) assessment of opinion leaders from 4 tribal blocks in Udaipur district with reference to health, sanitation and family planning.
  391. Knowledge, attitude and practice of family planning programme: experience of market research agency.
  392. Knowledge, attitudes and practice of family planning among women in the capital city of Niger, Central West Africa: a sample survey.
  393. Lack of impairment of fluocortolone disposition in oral contraceptive users.
  394. Lactational amenorrhea in urban poor women and its implications for use of contraception.
  395. Laparoscopy in voluntary surgical contraception. [La laparoscopie en la contraception chirurgicale volontaire.]
  396. Latent effect of oral contraceptives on breast cancer [letter]
  397. Latent effect of oral contraceptives on breast cancer. In reply [letter]
  398. Lesotho Planned Parenthood Association. 1987 annual report.
  399. Letter to the editor concerning "Labeling Guidance for Combination Oral Contraceptives" [letter]
  400. Levonorgestrel implant contraceptive during lactation: effect on infant's growth in one-year.
  401. LHRH analogues in female contraception. [Les analogues de la LH-RH en contraception feminine.]
  402. Liberians seldom rely on modern birth control -- fertility rates are high, ideal family size is large.
  403. Library catalogue of the Gambia Family Planning Association, Banjul, The Gambia.
  404. Lifestyles, contraception and parenthood: proceedings of a Workshop, Amsterdam, September 25-27, 1986.
  405. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
  406. List of free materials in family planning/maternal and child health, 1988.
  407. Liver diseases related to oral contraceptives.
  408. Liver tumor in long-term user of oral contraceptives.
  409. Long-acting hormonal contraception.
  410. Long-acting injectable steroidal contraception utilizing norethindrone microspheres.
  411. Long-term contraception for women.
  412. Looking at the costs of family planning.
  413. Low contraceptive prevalence in Sub-Saharan Africa: a reflection of low demand or poor supply?
  414. Low-dose oral contraceptives.
  415. Ludwig Haberlandt (1885-1932) and the development of hormonal contraception. [Ludwig Haberlandt (1885-1932) und die Entwicklung der hormonalen Kontrazeption.]
  416. Luteal contraception.
  417. Male attitudes towards family planning and gender equity in Grenada.
  418. Male contraception -- the current position.
  419. Male contraception in Korea.
  420. Male contraception.
  421. Male contraception.
  422. Male contraception: current status and future prospects.
  423. Male involvement in family planning.
  424. Male involvement in family planning: a bibliography of project descriptions and resources.
  425. The man in family planning programs. [L'homme dans les programmes de planification familiale.]
  426. Manufacturers phase out high-dose oral contraceptives.
  427. Marketing contraceptives in rural Thailand.
  428. The masculine side of planned parenthood: an explanatory analysis.
  429. MCH and family planning -- user perspectives and service constraints.
  430. MCH and family planning: a package deal.
  431. Measuring components of family planning program effort.
  432. Measuring contraceptive use failure and continuation: an overview of new approaches.
  433. Measuring the impact on fertility of family planning programmes in several African countries: data methods and results.
  434. Medroxyprogesterone acetate as an injectable contraceptive.
  435. Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome.
  436. Metabolic risks of oral contraception. [Risques metaboliques de la contraception orale.]
  437. Metamizol-caffeine elimination in females with increased serum aminotransferase activities treated with steroidal oral contraceptives. [Die Metamizol-Coffein-Elimination bei Frauen mit erhohten Aminotransferase-Aktivitaten im Serum unter steroidalen oralen Kontrazeptiva.]
  438. Mexico: promoting family planning services for men.
  439. Mid-term evaluation of the Population and Family Planning Support Project, Phase III (608-0171), Morocco.
  440. Mild side-effects of oral contraceptives. [Lettere bivirkninger ved p-pillebruk.]
  441. Model mothers motivate women in Thailand to use modern contraceptives.
  442. Modern contraception: a 1989 update.
  443. Modern family planning, sexual behavior and marriage status among women in Tanzania.
  444. Modernization, contraception and fertility change in India.
  445. Modernization, trends in desired family size and contraceptive use among the Yoruba: evidence from Oyo State survey.
  446. Modernizing family planning.
  447. Monthly injectable contraception with norethisterone enanthate plus estradiol valerate.
  448. Monthly injectable contraceptives.
  449. Mood, sexuality, oral contraceptives and the menstrual cycle.
  450. Morality and contraception. [Morale et contraception.]
  451. More contraceptive choices likely by end of century.
  452. More contraceptive choices likely by end of century.
  453. Morphofunctional and cytologic characteristics of the endocervix with the use of oral contraceptives. [Morfofunktsionalnye i tsitologicheskie osobennosti endotserviksa pri primenenii oralnykh kontratseptivov.]
  454. The most presumptuous pox--AIDS and contraception.
  455. Multicenter clinical study of levonorgestrel contraceptive implants. [Estudio clinico multicentrico con implantes anticonceptivos de levonorgestrel.]
  456. A multicenter German Democratic Republic (GDR) case-control study on cardiovascular risks of hormonal contraceptives. [Multizentrische DDR-Fall-Kontroll-Studie zum kardiovaskularen Risiko bei Anwendung hormonaler Kontrazeptiva.]
  457. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
  458. A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. contraceptive efficacy and side effects.
  459. Natality and family planning in three Bombay communities.
  460. National survey on family planning, fertility and health of the population of Morocco (ENPS) 1987: preliminary report, revised. [Enquete Nationale sur la Planification Familiale, la Fecondite et la Sante de la Population au Maroc (ENPS) 1987: rapport preliminaire, revise.]
  461. Natural family planning and pregnancy outcome.
  462. The Natural Family Planning Programme in Bangladesh.
  463. Natural family planning. A guide to provision of services.
  464. Natural family planning: a review and assessment.
  465. Natural family planning: very risky business.
  466. Natural methods of contraception.
  467. Natural methods of family planning: model project for scientific testing and controlled use, National Catholic Advisory Group. [Naturliche Methoden de Familienplanung: Modellprojekt zur wissenschaftlichen Uberprufung und kontrollierten Vermittlung, Katholische Bundesarbeitsgemeinschaft fur Beratung e. V.]
  468. Needs, costs and benefits of family planning.
  469. New approaches in vaginal contraception.
  470. The new birth-control book: a complete guide for women and men.
  471. New contraceptive methods and reproductive health.
  472. New data on oral contraceptives and breast cancer.
  473. New development in voluntary surgical contraception.
  474. New directions in family planning communication: 12 predictions for the 1990s.
  475. The new generation of monophasic oral contraceptives.
  476. New horizons in contraception.
  477. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women.
  478. The new population policy issued by the ruling party and principles for the future development of family planning in Taiwan.
  479. Nongovernmental organizations in international population and family planning.
  480. Norplant Fact Sheet no. 5: comparing family planning methods.
  481. Notes on family planning. Let's see now what the feminine sector thinks. [Apuntes sobre planificacion familiar. Veamos ahora que opina el sector femenino.]
  482. Obedience, assertiveness and planning for the future as precursors of sexual and contraceptive behavior in adolescents. [Obediencia, asertividad y planeacion al futuro como precursores de comportamiento sexual y anticonceptivo en adolescentes.]
  483. Observations with Anteovin in family planning advisory unit.
  484. Occurrence of few biological events in females in relation to literacy, economic status and adoption of family planning in rural and urban area of central Orissa, India.
  485. Offering Norplant as a contraceptive choice.
  486. Older women and family planning services.
  487. Omnibus Study on Family Planning -- September 1988 -- report on data from males.
  488. On the ability of blood pressure effects to explain the relation between oral contraceptives and cardiovascular disease.
  489. Operations research in the context of family planning and health programs, workshop held in Rabat, Morocco, April 1988]
  490. Opposition from husband as a constraint on wife's contraception use in Matlab, Bangladesh: a qualitative analysis.
  491. Oral contraception and its beneficial gynecological effects. [Contraception orale et actions benefiques sur la sphere gynecologique.]
  492. Oral contraception and ovarian function.
  493. Oral contraception in Japan: past, present, future.
  494. Oral contraception, glucid metabolism and monitoring criteria. [Contraception orale, metabolisme glucidique et criteres de surveillance.]
  495. Oral contraception. Monophasics vs. multiphasics -- is there a difference?
  496. Oral contraception: combined estrogen-progestagen. 2. Conditions of use. [Contraception orale: les oestroprogestatifs. 2. Conditions d'utilisation.]
  497. Oral contraceptive agents and breast cancer: a population-based case-control study.
  498. Oral contraceptive agents: current status.
  499. An oral contraceptive particularly suitable for women over 35.
  500. Oral contraceptive use and cerebral infarction. A review of twenty-two cases. [Contraception orale et accident vasculaire cerebral ischemique. A propos de vingt-deux observations.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.